200 related articles for article (PubMed ID: 38535328)
1. Application of Clinical Blood Metabogram to Type 2 Diabetes Mellitus.
Lokhov PG; Balashova EE; Trifonova OP; Maslov DL; Shestakova EA; Shestakova MV; Dedov II
Metabolites; 2024 Mar; 14(3):. PubMed ID: 38535328
[TBL] [Abstract][Full Text] [Related]
2. Clinical Blood Metabogram: Application to Overweight and Obese Patients.
Lokhov PG; Balashova EE; Trifonova OP; Maslov DL; Plotnikova OA; Sharafetdinov KK; Nikityuk DB; Tutelyan VA; Ponomarenko EA; Archakov AI
Metabolites; 2023 Jun; 13(7):. PubMed ID: 37512504
[TBL] [Abstract][Full Text] [Related]
3. Mass Spectrometric Blood Metabogram: Acquisition, Characterization, and Prospects for Application.
Lokhov PG; Balashova EE; Trifonova OP; Maslov DL; Grigoriev AI; Ponomarenko EA; Archakov AI
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675249
[TBL] [Abstract][Full Text] [Related]
4. Linking Clinical Blood Metabogram and Gut Microbiota.
Lokhov PG; Balashova EE; Maslov DL; Trifonova OP; Lisitsa AV; Markova YM; Stetsenko VV; Polyanina AS; Sheveleva SA; Sharafetdinov KK; Nikityuk DB; Tutelyan VA; Archakov AI
Metabolites; 2023 Oct; 13(10):. PubMed ID: 37887420
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and systemic metabolic changes in oral glucose tolerance test in 5340 individuals: an interventional study.
Wang Q; Jokelainen J; Auvinen J; Puukka K; Keinänen-Kiukaanniemi S; Järvelin MR; Kettunen J; Mäkinen VP; Ala-Korpela M
BMC Med; 2019 Nov; 17(1):217. PubMed ID: 31779625
[TBL] [Abstract][Full Text] [Related]
6. Beyond glucose: metabolic shifts in responses to the effects of the oral glucose tolerance test and the high-fructose diet in rats.
Lin S; Yang Z; Liu H; Tang L; Cai Z
Mol Biosyst; 2011 May; 7(5):1537-48. PubMed ID: 21350749
[TBL] [Abstract][Full Text] [Related]
7. Report of the committee on the classification and diagnostic criteria of diabetes mellitus.
; Seino Y; Nanjo K; Tajima N; Kadowaki T; Kashiwagi A; Araki E; Ito C; Inagaki N; Iwamoto Y; Kasuga M; Hanafusa T; Haneda M; Ueki K
J Diabetes Investig; 2010 Oct; 1(5):212-28. PubMed ID: 24843435
[TBL] [Abstract][Full Text] [Related]
8. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
[TBL] [Abstract][Full Text] [Related]
9. Plasma Targeted Metabolomics Analysis for Amino Acids and Acylcarnitines in Patients with Prediabetes, Type 2 Diabetes Mellitus, and Diabetic Vascular Complications.
Li X; Li Y; Liang Y; Hu R; Xu W; Liu Y
Diabetes Metab J; 2021 Mar; 45(2):195-208. PubMed ID: 33685035
[TBL] [Abstract][Full Text] [Related]
10. Associations between dietary intake and glucose tolerance in clinical and metabolomics-based metabotypes.
Rundblad A; Christensen JJ; Hustad KS; Bastani NE; Ottestad I; Holven KB; Ulven SM
Genes Nutr; 2023 Mar; 18(1):3. PubMed ID: 36899329
[TBL] [Abstract][Full Text] [Related]
11. Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants.
Urpi-Sarda M; Almanza-Aguilera E; Llorach R; Vázquez-Fresno R; Estruch R; Corella D; Sorli JV; Carmona F; Sanchez-Pla A; Salas-Salvadó J; Andres-Lacueva C
Diabetes Metab; 2019 Apr; 45(2):167-174. PubMed ID: 29555466
[TBL] [Abstract][Full Text] [Related]
12. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
13. High-Performance Liquid Chromatography-Mass Spectrometry-Based Lipid Metabolite Profiling of Acromegaly.
Wang M; Guo S; He M; Shao X; Feng L; Yu Y; Gong W; Liu Q; Melnikov V; Wang X; He Z; Jiang L; Chen M; Sun J; Cai J; Zhao Y; Li Y; Tritos NA; Hu Z; Zhang Z
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31930294
[TBL] [Abstract][Full Text] [Related]
14. Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics.
Xu F; Tavintharan S; Sum CF; Woon K; Lim SC; Ong CN
J Clin Endocrinol Metab; 2013 Jun; 98(6):E1060-5. PubMed ID: 23633210
[TBL] [Abstract][Full Text] [Related]
15. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting.
Suhre K; Meisinger C; Döring A; Altmaier E; Belcredi P; Gieger C; Chang D; Milburn MV; Gall WE; Weinberger KM; Mewes HW; Hrabé de Angelis M; Wichmann HE; Kronenberg F; Adamski J; Illig T
PLoS One; 2010 Nov; 5(11):e13953. PubMed ID: 21085649
[TBL] [Abstract][Full Text] [Related]
16. Maternal Metabolites Associated With Gestational Diabetes Mellitus and a Postpartum Disorder of Glucose Metabolism.
Liu Y; Kuang A; Bain JR; Muehlbauer MJ; Ilkayeva OR; Lowe LP; Metzger BE; Newgard CB; Scholtens DM; Lowe WL
J Clin Endocrinol Metab; 2021 Oct; 106(11):3283-3294. PubMed ID: 34255031
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
18. The role of metabolomics in personalized medicine for diabetes.
Chowdhury S; Faheem SM; Nawaz SS; Siddiqui K
Per Med; 2021 Sep; 18(5):501-508. PubMed ID: 34406076
[TBL] [Abstract][Full Text] [Related]
19. [Risk-based prediabetes screening in a rural general practice - oral glucose tolerance test or glycated hemoglobin?].
Galvács H; Szabó J; Balogh Z
Orv Hetil; 2019 Dec; 160(50):1976-1983. PubMed ID: 31814420
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
